INSYS Therapeutics, Inc. - Product Pipeline Review - 2016

  • ID: 3720444
  • Company Profile
  • 45 pages
  • Global Markets Direct
  • Insys Therapeutics Inc
1 of 4
INSYS Therapeutics, Inc. - Product Pipeline Review - 2016

Summary

‘INSYS Therapeutics, Inc. - Product Pipeline Review - 2016’, provides an overview of the INSYS Therapeutics, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by INSYS Therapeutics, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of INSYS Therapeutics, Inc.
- The report provides overview of INSYS Therapeutics, Inc. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses INSYS Therapeutics, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features INSYS Therapeutics, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate INSYS Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for INSYS Therapeutics, Inc.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding INSYS Therapeutics, Inc.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

INSYS Therapeutics, Inc. Snapshot

INSYS Therapeutics, Inc. Overview

Key Information

Key Facts

INSYS Therapeutics, Inc. - Research and Development Overview

Key Therapeutic Areas

INSYS Therapeutics, Inc. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

INSYS Therapeutics, Inc. - Pipeline Products Glance

INSYS Therapeutics, Inc. - Late Stage Pipeline Products

Pre-Registration Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

INSYS Therapeutics, Inc. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

INSYS Therapeutics, Inc. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

INSYS Therapeutics, Inc. - Drug Profiles

dronabinol

Product Description

Mechanism of Action

R&D Progress

buprenorphine hydrochloride

Product Description

Mechanism of Action

R&D Progress

Cannabidiol

Product Description

Mechanism of Action

R&D Progress

(buprenorphine hydrochloride + naloxone hydrochloride)

Product Description

Mechanism of Action

R&D Progress

naloxone hydrochloride

Product Description

Mechanism of Action

R&D Progress

ondansetron hydrochloride

Product Description

Mechanism of Action

R&D Progress

paclitaxel

Product Description

Mechanism of Action

R&D Progress

cetirizine hydrochloride + cromolyn sodium

Product Description

Mechanism of Action

R&D Progress

diclofenac sodium

Product Description

Mechanism of Action

R&D Progress

ketorolac tromethamine

Product Description

Mechanism of Action

R&D Progress

sildenafil citrate

Product Description

Mechanism of Action

R&D Progress

INSYS Therapeutics, Inc. - Pipeline Analysis

INSYS Therapeutics, Inc. - Pipeline Products by Target

INSYS Therapeutics, Inc. - Pipeline Products by Route of Administration

INSYS Therapeutics, Inc. - Pipeline Products by Molecule Type

INSYS Therapeutics, Inc. - Pipeline Products by Mechanism of Action

INSYS Therapeutics, Inc. - Recent Pipeline Updates

INSYS Therapeutics, Inc. - Dormant Projects

INSYS Therapeutics, Inc. - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

Monoclonal Antibody Conjugate to Target Mesothelin for Oncology

INSYS Therapeutics, Inc. - Company Statement

INSYS Therapeutics, Inc. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

INSYS Therapeutics, Inc., Key Information

INSYS Therapeutics, Inc., Key Facts

INSYS Therapeutics, Inc. - Pipeline by Indication, 2016

INSYS Therapeutics, Inc. - Pipeline by Stage of Development, 2016

INSYS Therapeutics, Inc. - Monotherapy Products in Pipeline, 2016

INSYS Therapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2016

INSYS Therapeutics, Inc. - Pre-Registration, 2016

INSYS Therapeutics, Inc. - Phase III, 2016

INSYS Therapeutics, Inc. - Phase II, 2016

INSYS Therapeutics, Inc. - Phase I, 2016

INSYS Therapeutics, Inc. - Preclinical, 2016

INSYS Therapeutics, Inc. - Pipeline by Target, 2016

INSYS Therapeutics, Inc. - Pipeline by Route of Administration, 2016

INSYS Therapeutics, Inc. - Pipeline by Molecule Type, 2016

INSYS Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2016

INSYS Therapeutics, Inc. - Recent Pipeline Updates, 2016

INSYS Therapeutics, Inc. - Dormant Developmental Projects,2016

INSYS Therapeutics, Inc. - Discontinued Pipeline Products, 2016

INSYS Therapeutics, Inc., Other Locations

INSYS Therapeutics, Inc., Subsidiaries

List of Figures

INSYS Therapeutics, Inc. - Pipeline by Top 10 Indication, 2016

INSYS Therapeutics, Inc. - Pipeline by Stage of Development, 2016

INSYS Therapeutics, Inc. - Monotherapy Products in Pipeline, 2016

INSYS Therapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2016

INSYS Therapeutics, Inc. - Pipeline by Top 10 Target, 2016

INSYS Therapeutics, Inc. - Pipeline by Route of Administration, 2016

INSYS Therapeutics, Inc. - Pipeline by Molecule Type, 2016

INSYS Therapeutics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll